Lupin gets approval from USFDA for ulcer drug
Lupin has received an approval from USFDA to market a generic drug in the US to treat ulcer
Drug firm Lupin has received a nod from US Food and Drug Administration to market the generic version of AstraZeneca's Prilosec delayed-release capsules, to treat ulcer. Lupin’s drug Omeprazole delayed-release capsules will be introduced in the strength of 40 mg in the American market.
The drug is also used for healing of erosive esophagitis and pathological hypersecretory conditions.
The Mumbai-based company's Omeprazole delayed-release capsules are the generic equivalent of AstraZeneca's Prilosec delayed-release capsules, which are indicated for the treatment of duodenal ulcer, gastric ulcer and gastro esophageal reflux disease (GERD), as confirmed by PTI.
Drug firm Lupin has received a nod from US Food and Drug Administration to market the generic version of AstraZeneca's Prilosec delayed-release capsules, to treat ulcer. Lupin’s drug Omeprazole delayed-release capsules will be introduced in the strength of 40 mg in the American market.
The drug is also used for healing of erosive esophagitis and pathological hypersecretory conditions.
The Mumbai-based company's Omeprazole delayed-release capsules are the generic equivalent of AstraZeneca's Prilosec delayed-release capsules, which are indicated for the treatment of duodenal ulcer, gastric ulcer and gastro esophageal reflux disease (GERD), as confirmed by PTI.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.